On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2024 Northeastern Co-Ops to learn what sparked their interest in Cerevel, their predictions for the future in the world of drug discovery, and what they value most about the co-op program.By Dr. John Renger

On the next episode of Drug Hunters, Dr. John Renger catches up with Cerevel’s own TMEM175 Compound team to learn more about the complexities that accompany screening this gene. We hear about both the goals and challenges in this program.By Dr. John Renger

On this episode of Drug Hunters, Dr. John Renger interviews his executive assistant, Kristen Larrabee. Kristen recounts her early days as an assistant in various industries, and what led her to join Cerevel. She describes candidly what it’s like to support Dr. John Renger, and his larger organization, with some creative strategies. Enjoy!…

On this episode of Cerevel Drug Hunters, Dr. John Renger interviews Dr. Srinivas Chakilam, Vice President, Drug Metabolism and Pharmacokinetics (DMPK). We get an inside look into what Srinivas and his team do at Cerevel to uncover and understand molecule properties from the research stage all the way to filing NDAs (New Drug Applications). They hel…

On the next episode of Drug Hunters, Dr. John Renger sits down with Cerevel’s Senior Director of Research Operations, Dr. Kim Kerr. Kim takes us through her group’s mission to support the scientists in what they do; science! We get a closer inside look at how her team acts as the operational glue for the CSO organization in providing nonclinical pr…

On the next episode of Drug Hunters, Dr. John Renger interviews two members from CereVets, Cerevel’s newly launched Veteran Employee Resource Group. The episode features Jack Homsher VP, Human Resources (former Senior Chief, and SEAL, US Navy), and Francisco Guzman, Principal Scientist, Process Development (former First-class Petty Officer, US Navy…

On this episode of Cerevel Drug Hunters, Dr. John Renger sits down one-on-one with Cerevel’s own SVP of CMC Technical Operations, Dr. Andy Clausen. We get an inside look into the Technical Operations and CMC teams at Cerevel, and learn about Andy’s exciting career journey. You won’t want to miss this!…

On this episode of Cerevel Drug Hunters, Dr. John Renger sits down with our VP of Biology, Dr. Phil Iredale. Phil dives into his role of managing the Biology department, all targets, how we arrive at some of the new programs we decide to run, and the mechanisms behind the drugs we are developing. We also get a glimpse into the journey that led Phil…

On the next episode of Drug Hunters, Dr. John Renger interviews Cerevel’s Vice President of Genetics & Target Identification, Dr. Dave Stone. Dave chats about the genes we target, and how his team strategically thinks about the programs we want to build out in our early pipeline in order to deliver new therapeutics to our patients.…

On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2023 Northeastern Co-Ops to gain insight into what drew these students to Cerevel initially, their diverse career aspirations, and what they value most from the co-op program.By Dr. John Renger

On the next episode of Drug Hunters, Dr. John Renger interviews Cerevel’s Senior Director and Head of Search and Evaluation, Dr. Yong Mi Choi. Yong Mi describes what goes into her role of identifying transformative partnership opportunities and finding new technologies that can accelerate the progress of our existing early discovery programs.…

On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2022 Northeastern Co-Ops to gain insight into what drew these students to Cerevel initially, their diverse career aspirations, and what they valued most from the co-op program.By Dr. John Renger

Our highly anticipated second podcast features Dr. John Renger interviewing Cerevel’s Vice President of Clinical Pharmacology & Pharmacometrics, Dr. Sridhar Duvvuri. Sridhar describes what motivates and drives him and his team in their work at Cerevel to treat unmet patient needs from the pre-clinical to bedside phase of treatment.…

The first podcast features Dr. Rick Briscoe, Senior Vice President, Safety Assessment and Research Operations, discussing his journey, aspirations, and personal motivation for developing new solutions for people living with neuroscience diseases.By Dr. John Renger